Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063008) titled 'A Multicenter Retrospective Observational Study of Unresectable Hepatocellular Carcinoma Treated with Lenvatinib-Pretreated Transarterial Chemoembolization (LEN-TACE)' on Sept. 21.
Study Type:
Observational
Primary Sponsor:
Institute - Kurume University
Condition:
Condition - Unresectable Hepatocellular Carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To conduct a multicenter, retrospective observational study of patients with unresectable HCC who underwent LEN-TACE therapy, with the aim of elucidating its efficacy, safety, and prognostic factors in ...